Clinical Trial Update: Coenzyme Q10 as Treatment for Long Term COVID-19 [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Coenzyme Q10 as treatment for long-term COVID-19 has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Long-term COVID-19

Drugs mentioned

• Coenzyme Q10 (Coenzyme Q10)

Snippet

Sponsor: Aarhus University Hospital | Conditions: Covid19, Long Term Covid19 | Phase 2 | Status: COMPLETED